Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.72 |
| ▸ | ALOX5 | P09917 | 2/20 | 0.72 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.72 |
| ▸ | AR | P10275 | 1/20 | 0.72 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.72 |
| ▸ | TRPM8 | Q7Z2W7 | 1/20 | 0.72 |
| ▸ | TSHR | P16473 | 2/20 | 0.62 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.62 |
| ▸ | GAA | P10253 | 1/20 | 0.62 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.62 |
| ▸ | TAAR1 | Q96RJ0 | 2/20 | 0.61 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.61 |
| ▸ | FOS | P01100 | 1/20 | 0.59 |
| ▸ | TTR | P02766 | 1/20 | 0.59 |
| ▸ | JUN | P05412 | 1/20 | 0.59 |
| ▸ | NR3C1 | P04150 | 1/20 | 0.59 |
| ▸ | HSD17B1 | P14061 | 1/20 | 0.59 |
| ▸ | HSD17B2 | P37059 | 1/20 | 0.59 |
| ▸ | LMNA | P02545 | 1/20 | 0.59 |
| ▸ | GLA | P06280 | 1/20 | 0.59 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL917723 | 1.00 | ALDH1A1 (0.72) | ALDH1A1ALOX5CYP3A4ARPTGS1 | |
| SCHEMBL4750264 | 0.88 | ALDH1A1 (0.57) | ALDH1A1ALOX5CYP3A4ARPTGS1 | |
| SCHEMBL17843665 | 0.87 | ALDH1A1 (0.74) | ALDH1A1ALOX5CYP3A4ARPTGS1 | |
| SCHEMBL17843664 | 0.87 | ALDH1A1 (0.74) | ALDH1A1ALOX5CYP3A4ARPTGS1 | |
| Eugenol SCHEMBL3693444 | 0.85 | ALDH1A1 (0.76) | ALDH1A1ALOX5CYP3A4ARPTGS1 | |
| SCHEMBL5922898 | 0.85 | ALDH1A1 (0.72) | ALDH1A1ALOX5CYP3A4ARPTGS1 | |
| SCHEMBL3390749 | 0.85 | GAA (0.62) | ALDH1A1ALOX5CYP3A4ARPTGS1 | |
| SCHEMBL26249512 | 0.85 | ALDH1A1 (0.72) | ALDH1A1ALOX5CYP3A4ARPTGS1 | |
| SCHEMBL10399150 | 0.85 | ALDH1A1 (0.62) | ALDH1A1ALOX5CYP3A4ARPTGS1 | |
| SCHEMBL12329797 | 0.85 | ALDH1A1 (0.62) | ALDH1A1ALOX5CYP3A4ARPTGS1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 29 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250347684-A1 | METABOLIC BIOMARKERS IN BLOOD SERUM FOR DIAGNOSIS OF ALZHEIMER'S DISEASE | UNIV TEXAS (US) | 2025-11-13 | — | — | US | claimed |
| CN-119708623-A | Heat stabilizer and preparation method thereof | 西尼尔(山东)新材料科技有限公司 | 2025-03-28 | — | — | CN | claimed |
| CN-119083211-A | Apocynum venetum fiber biological dyeing method based on laccase catalytic polymerization reaction | 新疆大学 | 2024-12-06 | — | — | CN | claimed |
| WO-2024194018-A1 | METHOD FOR PRODUCING CORYTUBERINE AND SALUTARIDINE | Universität Graz (AT) | 2024-09-26 | — | — | WO | claimed |
| EP-4431612-A1 | PROCESS FOR THE PREPARATION OF CORORYLOURIN AND SALUTARIDINE | Universität Graz (AT) | 2024-09-18 | — | — | EP | claimed |
| EP-4356894-A1 | SUSTAINABLE PRODUCT WITH MALODORS | Beiersdorf AG (DE) | 2024-04-24 | — | — | EP | claimed |
| US-20250347684-A1 | METABOLIC BIOMARKERS IN BLOOD SERUM FOR DIAGNOSIS OF ALZHEIMER'S DISEASE | UNIV TEXAS (US) | 2025-11-13 | — | — | US | disclosed |
| US-12435345-B2 | Prehydrolysate fermentability in biomass pretreatment | UNIVERSITY OF CINCINNATI (US) | 2025-10-07 | — | — | US | disclosed |
| US-20250113823-A1 | Arthropod Control Compositions | FIRMENICH SA (CH) | 2025-04-10 | — | — | US | disclosed |
| CN-119708623-A | Heat stabilizer and preparation method thereof | 西尼尔(山东)新材料科技有限公司 | 2025-03-28 | — | — | CN | disclosed |
| WO-2025026525-A1 | HETEROCYCLIC COMPOUNDS AS PHYSIOLOGICAL COOLANTS | SYMRISE AG (DE) | 2025-02-06 | — | — | WO | disclosed |
| CN-111315360-B | Resiniferatoxin formulations | 索伦托药业有限公司 | 2025-01-17 | — | — | CN | disclosed |
| CN-119199049-A | Application of pathway enrichment analysis differential metabolite in drug analysis for treating climacteric syndrome | 扬子江药业集团四川海蓉药业有限公司 | 2024-12-27 | — | — | CN | disclosed |
| US-11788228-B2 | Methods for processing lignocellulosic material | CMBLU ENERGY AG (DE) | 2023-10-17 | — | — | US | disclosed |
| WO-2023139053-A1 | ARTHROPOD CONTROL COMPOSITIONS | FIRMENICH SA (CH) | 2023-07-27 | — | — | WO | disclosed |
| CN-116298015-A | Detection method of vanilla mandelic acid and homovanillic acid in urine and application thereof | 北京豪思生物科技股份有限公司 | 2023-06-23 | — | — | CN | disclosed |
| CN-115397986-A | Oligonucleotide-encoded chemical libraries, related systems, devices, and methods for detecting, analyzing, quantifying, and testing biological agents/genetic characteristics | 普莱克斯姆公司 | 2022-11-25 | — | — | CN | disclosed |
| CN-113046264-B | Streptomyces for producing 3-methylthiopropanol and application of streptomyces in preventing and treating plant oomycetes and fungal diseases | 重庆大学 | 2022-10-04 | — | — | CN | disclosed |
| US-20220251610-A1 | Prehydrolysate Fermentability in Biomass Pretreatment | UNIVERSITY OF CINCINNATI (US) | 2022-08-11 | — | — | US | disclosed |
| US-11326216-B2 | Process for hydrolysis of oligosaccharides | RENMATIX, INC. (US) | 2022-05-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11788228-B2 | Methods for processing lignocellulosic material | DCXR, LCT, AGL | ALDH1A1 2496/4885ALOX5 338/4885CYP3A4 794/4885 |
| US-20250113823-A1 | Arthropod Control Compositions | AGO2, EXOSC9, C5 | ALDH1A1 3700/4885ALOX5 1368/4885CYP3A4 3083/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.